This laboratory test combines a powerful analytical technique with specific markers to identify and classify blood cell malignancies. Flow cytometry analyzes individual cells as they pass through a laser beam, measuring properties like size, granularity, and the presence of specific proteins on the cell surface. Panels designed for leukemia and lymphoma diagnostics use fluorescently tagged antibodies that bind to these proteins, allowing for detailed characterization of the abnormal cell populations. For instance, a panel might identify an overabundance of immature white blood cells expressing specific markers, suggesting a particular leukemia subtype.
The detailed cellular information provided by this type of analysis is crucial for accurate diagnosis, prognosis, and treatment planning for these cancers. It helps distinguish between different leukemia and lymphoma subtypes, which can have drastically different clinical courses and treatment responses. Historically, diagnoses relied heavily on microscopic examination of blood smears and bone marrow biopsies. The advent of these targeted diagnostic panels has significantly improved the precision and speed of diagnosis, enabling earlier intervention and personalized therapeutic strategies.
